Core Scientific, Inc. (NASDAQ:CORZ) Shares Purchased by Van ECK Associates Corp

Van ECK Associates Corp grew its holdings in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 22.9% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 1,616,944 shares of the company's stock after buying an additional 300,942 shares during the quarter. Van ECK Associates Corp owned approximately 0.63% of Core Scientific worth $19,177,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Capstone Investment Advisors LLC purchased a new position in shares of Core Scientific in the 1st quarter valued at approximately $307,000. Concurrent Investment Advisors LLC bought a new position in shares of Core Scientific in the 1st quarter worth about $417,000. Barings LLC bought a new stake in Core Scientific during the first quarter worth about $36,515,000. Blair William & Co. IL bought a new position in shares of Core Scientific during the first quarter valued at approximately $1,156,000. Finally, Dorsey & Whitney Trust CO LLC purchased a new stake in shares of Core Scientific in the 1st quarter worth approximately $122,000.

Core Scientific Trading Up 4.4 %

Shares of NASDAQ:CORZ traded up $0.55 on Tuesday, reaching $13.15. The company had a trading volume of 4,079,505 shares, compared to its average volume of 8,685,138. Core Scientific, Inc. has a 52-week low of $2.61 and a 52-week high of $14.64. The firm's 50 day simple moving average is $11.95 and its 200-day simple moving average is $9.14.

Core Scientific (NASDAQ:CORZ - Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported ($4.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($4.47). The firm had revenue of $141.10 million during the quarter, compared to analyst estimates of $128.58 million. The company's quarterly revenue was up 11.2% compared to the same quarter last year. As a group, equities research analysts predict that Core Scientific, Inc. will post 0.81 earnings per share for the current fiscal year.

Insider Transactions at Core Scientific

In other news, insider Todd M. Duchene sold 11,582 shares of the firm's stock in a transaction on Friday, August 16th. The stock was sold at an average price of $9.41, for a total value of $108,986.62. Following the completion of the sale, the insider now owns 1,686,474 shares of the company's stock, valued at $15,869,720.34. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Core Scientific news, CFO Denise Marie Brucia Sterling sold 8,752 shares of Core Scientific stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $9.41, for a total transaction of $82,356.32. Following the completion of the transaction, the chief financial officer now owns 122,217 shares in the company, valued at approximately $1,150,061.97. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Todd M. Duchene sold 11,582 shares of Core Scientific stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $108,986.62. Following the transaction, the insider now owns 1,686,474 shares of the company's stock, valued at $15,869,720.34. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders acquired 12,761 shares of company stock valued at $127,080 in the last quarter.

Analyst Upgrades and Downgrades

CORZ has been the subject of several recent analyst reports. HC Wainwright boosted their price target on Core Scientific from $11.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday, July 10th. Macquarie started coverage on Core Scientific in a report on Wednesday, September 25th. They issued an "outperform" rating and a $16.00 price target on the stock. Needham & Company LLC lifted their price objective on shares of Core Scientific from $16.00 to $17.00 and gave the company a "buy" rating in a research report on Wednesday, October 23rd. Sanford C. Bernstein restated an "outperform" rating and set a $17.00 target price on shares of Core Scientific in a research report on Tuesday, September 10th. Finally, B. Riley boosted their price target on shares of Core Scientific from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Friday, October 11th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $16.71.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.